[ad_1]
Health Commissioner Stella Kiriakides reacted that, according to the Hungarian government, Brussels was to blame for not being able to start the national vaccination program as quickly as the British: the Budapest leadership could have granted an emergency permit, but then all liability and compensation claims would have burdened the government, writes Euronews.
Even at the top of the rule of law debate, in an interview on December 4, Prime Minister Viktor Orbán spoke about what he thought the inertia of Brussels was showing. that Pfizer’s coronavirus vaccine will be distributed for the first time in the United States and Great Britain, pending approval in the EU. Here you see that the British did well because they could already take a separate path. Later, several members of the Hungarian government blamed the European Union that vaccination could only begin at the end of December at home, and on Tuesday night the Secretary of State for Foreign Affairs, Tamás Menczer, spoke directly about the fault of Brussels. .
“Due to the mistakes of Brussels, we are lagging behind the United States, England and Israel in terms of the coronavirus vaccine,” the politician said according to Euronews, Menczer said that the EU has also delayed a contract and a late license. However, the portal also publishes the response of the EU Health Commissioner Stella Kiriakides, who made it clear: Hungary could have gone its own way if it had wanted, so it does not consider the evasion of the Hungarian government to be true.
The essence of the procurement of vaccines in Brussels is that, instead of the 27 Member States, the committee negotiates and concludes agreements with the manufacturers, so that all countries have access to the vaccine on equal terms. For example, 300 million Pfizer-BioNtech vaccines, so far the only approved in Europe, have been ordered and hundreds of millions more are being traded. That’s just double the 200 million lots ordered by the United States. According to Kiriakides, it immediately fails here for Menczer to claim that these countries have asked for “much larger quantities.” He also notes that the purchase has been agreed with six companies, but that the number of units tied does not affect the speed of delivery of the vaccines, but that supply is interrupted by the limited capacity of the manufacturers.
“When we launched our vaccination strategy in June, there was a lot of uncertainty about whether or how many vaccines will be successful. In the last few months, we have created a portfolio of six vaccines, of which the BioNTech / Pfizer vaccines have already been approved and all of the vaccine could be approved soon. I don’t think there will be a delay. The current difficulties are not related to orders but to bottlenecks in production. However, this will improve in the coming weeks and months, “the union quoted the union as saying. EU. Commissioner of Health.
Kirikádes also pointed out that licensing was slower on its own, but Pfizer also entered the market in the UK and the US with emergency licenses, and in the UK Hungary could have lived with it ago. one month at the same time as the UK. However, if they had so decided, all liability and compensation claims would be assumed by the Hungarian government.
[ad_2]
